chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Exercise tolerance decreased, Palpitations, Peripheral swelling
Clinical narrative: Shortness of breath.  Heart palpitations.  Swelling in feet.  Exercise intolerance.  Resolved in a couple of weeks.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Spondylitis
Clinical narrative: Significant increase in Arthritis in my hands, lower back, neck and toes.  2% Voltarol gives temporary relief.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Immediate post-injection reaction, Limb discomfort, Loss of personal independence in daily activities, Paraesthesia
Clinical narrative: Patient did not immediately report any issues upon receipt of vaccine. She reported today that she has been having a problem with her Left arm ever since receiving the first dose of Moderna in September 2021. She said at the time of the vaccination, she immediately felt "tingling run down her arm." She reports that since this dose, she continues to sporadically feel "tingling" and her arm will "fall asleep" below the elbow and feel "heavy" from time to time. She has recently consulted a doctor because the symptoms are starting to affect her daily life. The prescriber is researching if she may have a vaccine related injury.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray normal
Clinical narrative: Patient did not immediately report any issues upon receipt of vaccine. She reported today that she has been having a problem with her Left arm ever since receiving the first dose of Moderna in September 2021. She said at the time of the vaccination, she immediately felt "tingling run down her arm." She reports that since this dose, she continues to sporadically feel "tingling" and her arm will "fall asleep" below the elbow and feel "heavy" from time to time. She has recently consulted a doctor because the symptoms are starting to affect her daily life. The prescriber is researching if she may have a vaccine related injury.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram, Anticoagulant therapy, Atrial fibrillation, Cardiac ablation, Cardiac failure congestive
Clinical narrative: Shortness of breath, heart palpitations, cough, exercise intolerance, some nausea/vomiting, pain in left lower leg, fluid retention, swelling in feet.  Symptoms progressed in severity.  Admitted to hospital week of Feb 6 for five days.  Diagnosed with deep vein thrombosis is left leg.  Pulmonary embolisms.  Congestive heart failure.  Tachycardia.  Atrial fibrillation.  Treated with blood thinner, diuretics, beta blockers.  Cardioversion.  Catheter radiofrequency atrial ablation.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Cardioversion, Cough, Deep vein thrombosis, Dyspnoea, Electrocardiogram
Clinical narrative: Shortness of breath, heart palpitations, cough, exercise intolerance, some nausea/vomiting, pain in left lower leg, fluid retention, swelling in feet.  Symptoms progressed in severity.  Admitted to hospital week of Feb 6 for five days.  Diagnosed with deep vein thrombosis is left leg.  Pulmonary embolisms.  Congestive heart failure.  Tachycardia.  Atrial fibrillation.  Treated with blood thinner, diuretics, beta blockers.  Cardioversion.  Catheter radiofrequency atrial ablation.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Exercise tolerance decreased, Fluid retention, Magnetic resonance imaging, Nausea, Pain in extremity
Clinical narrative: Shortness of breath, heart palpitations, cough, exercise intolerance, some nausea/vomiting, pain in left lower leg, fluid retention, swelling in feet.  Symptoms progressed in severity.  Admitted to hospital week of Feb 6 for five days.  Diagnosed with deep vein thrombosis is left leg.  Pulmonary embolisms.  Congestive heart failure.  Tachycardia.  Atrial fibrillation.  Treated with blood thinner, diuretics, beta blockers.  Cardioversion.  Catheter radiofrequency atrial ablation.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Peripheral swelling, Polyuria, Pulmonary embolism, Tachycardia
Clinical narrative: Shortness of breath, heart palpitations, cough, exercise intolerance, some nausea/vomiting, pain in left lower leg, fluid retention, swelling in feet.  Symptoms progressed in severity.  Admitted to hospital week of Feb 6 for five days.  Diagnosed with deep vein thrombosis is left leg.  Pulmonary embolisms.  Congestive heart failure.  Tachycardia.  Atrial fibrillation.  Treated with blood thinner, diuretics, beta blockers.  Cardioversion.  Catheter radiofrequency atrial ablation.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound scan, Vomiting
Clinical narrative: Shortness of breath, heart palpitations, cough, exercise intolerance, some nausea/vomiting, pain in left lower leg, fluid retention, swelling in feet.  Symptoms progressed in severity.  Admitted to hospital week of Feb 6 for five days.  Diagnosed with deep vein thrombosis is left leg.  Pulmonary embolisms.  Congestive heart failure.  Tachycardia.  Atrial fibrillation.  Treated with blood thinner, diuretics, beta blockers.  Cardioversion.  Catheter radiofrequency atrial ablation.
Age: 75.0
Sex: M
Vaccine: FLU4
Symptoms: Erythema, Feeling hot, Flushing, Injection site rash, Pain in extremity
Clinical narrative: At 10pm on August 5th, 2022, the patient started feeling hot and flush while working.  He received his Influenza vaccine 3.75 hours prior.  His arm became red and warm.  It swelled up a little bit.  It has been sore for 2 days and notified the pharmacy 2 days post injection.  He woke up on August 7, 2022 and it was still pink and had several small bumps at the injection.  The pharmacy did not use any Latex products while administering the vaccine.  He has not had any previous reactions to influenza or other vaccinations in the past per conversations with the patient.
Age: 75.0
Sex: M
Vaccine: FLU4
Symptoms: Peripheral swelling, Skin warm
Clinical narrative: At 10pm on August 5th, 2022, the patient started feeling hot and flush while working.  He received his Influenza vaccine 3.75 hours prior.  His arm became red and warm.  It swelled up a little bit.  It has been sore for 2 days and notified the pharmacy 2 days post injection.  He woke up on August 7, 2022 and it was still pink and had several small bumps at the injection.  The pharmacy did not use any Latex products while administering the vaccine.  He has not had any previous reactions to influenza or other vaccinations in the past per conversations with the patient.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Resident asymptomatic at this time.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Herpes zoster, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Shingles outbreak after 2nd vaccine. 2 breakthrough covid-19 cases @2 months and 3 months after 3rd vaccine, (2 separate cases).
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Blood pressure increased, Heart rate increased, Palpitations, Throat tightness
Clinical narrative: Approximately 15-30 minutes after receiving dose of Tdap vaccine from Pharmacy, my throat started to feel tight and my heart started to palpitate.  I quickly drank 3 bottles of water to try to help feeling subside then called EMS.  Within 7 minutes Paramedics arrived took vitals.  Blood pressure and pulse rate were elevated.  Throat had not constricted any more at this point.  4 minutes or so later, paramedics arrived.  Retook BP and pulse rate.  They were both lower.  I chose not to go to the Emergency Department since symptoms were subsiding.
Age: 62.0
Sex: M
Vaccine: UNK
Symptoms: Chills, Decreased appetite, Feeling abnormal, Headache, Hypersomnia
Clinical narrative: sleep, sleep, sleep, culiminating in fever one night, chills, low grade headache for 4 days, could not function, could not work, could not think clearly, loss of appetite and one day of vomiting; tried to drive to work and would turn around and come home because foggy
Age: 62.0
Sex: M
Vaccine: UNK
Symptoms: Impaired work ability, Mobility decreased, Pyrexia, Thinking abnormal, Vomiting
Clinical narrative: sleep, sleep, sleep, culiminating in fever one night, chills, low grade headache for 4 days, could not function, could not work, could not think clearly, loss of appetite and one day of vomiting; tried to drive to work and would turn around and come home because foggy
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Appendicectomy, Biliary adenoma, Blood test abnormal, Carbohydrate antigen 125 increased
Clinical narrative: I began to feel my stomach become hard, bloated and constipated, went to OB doctor and family doctor and was told I was just constipated and treated for that for several months.  I started feeling pain in May and went to ER where a CT was done and was told I had a tumor.  Treatment was to have tumor removed, total hysterectomy and appendix removed.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Constipation, Cystoscopy abnormal, Hysterectomy, Induration
Clinical narrative: I began to feel my stomach become hard, bloated and constipated, went to OB doctor and family doctor and was told I was just constipated and treated for that for several months.  I started feeling pain in May and went to ER where a CT was done and was told I had a tumor.  Treatment was to have tumor removed, total hysterectomy and appendix removed.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Neoplasm, Pain, Salpingo-oophorectomy bilateral, Tumour excision
Clinical narrative: I began to feel my stomach become hard, bloated and constipated, went to OB doctor and family doctor and was told I was just constipated and treated for that for several months.  I started feeling pain in May and went to ER where a CT was done and was told I had a tumor.  Treatment was to have tumor removed, total hysterectomy and appendix removed.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swelling of lymph nodes in neck and arm pit on left side of body occurs next day after vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given after Beyond use date
Age: 40.0
Sex: F
Vaccine: UNK
Symptoms: Hypoaesthesia, Night sweats, Paraesthesia, Postural orthostatic tachycardia syndrome, Throat irritation
Clinical narrative: Patient felt like her throat was scratchy, she later developed night sweats, transient numbness / tingling in her extremities, and POTS
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Arm started swelling 3 inches down from the injection site with burning. Skin was red and feverish. Patient took acetaminophen to treat. Patient reports improvement of symptoms 5 days post vaccination.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Muscle tightness
Clinical narrative: Sever chills Extreme tightness in chest muscle?s that lasted 4 hours for two nights in a row
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: A 3rd dose of Shingrix was given on 06/06/2022. The patient already received 2 doses of Shingrix at the other healthcare facilities. These information was found on system when the patient came in on 08/06/2022. Unknown adverse event(s).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Asthenia, Diarrhoea, Dizziness, Dysstasia
Clinical narrative: Approximately 2 weeks after my 2nd shot in the Pfizer 2-shot initial vaccine series, I developed intense fatigue, orthostatic hypotension, GI distress (low abdominal pain and diarrhea), tremor. If I stop for more than a minute, I developed tachycardia, profuse sweating, weakness /feeling like I was going to faint.  This persisted  in a severe state for 6 months, at which point I slowly became better. During this time, I was non-functional. Oddly, I also developed tiny stinging skin bumps on my torso and arms. At this time, I continue to have abnormal exertional fatigue, tremor, and if standing for long, tachycardia, increased tremor, followed in 30 - 60 min. by GI distress. I am MUCH better than I was, but my functioning continues to be impaired.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Electromyogram abnormal, Fatigue, Gastrointestinal disorder, Hyperhidrosis, Laboratory test
Clinical narrative: Approximately 2 weeks after my 2nd shot in the Pfizer 2-shot initial vaccine series, I developed intense fatigue, orthostatic hypotension, GI distress (low abdominal pain and diarrhea), tremor. If I stop for more than a minute, I developed tachycardia, profuse sweating, weakness /feeling like I was going to faint.  This persisted  in a severe state for 6 months, at which point I slowly became better. During this time, I was non-functional. Oddly, I also developed tiny stinging skin bumps on my torso and arms. At this time, I continue to have abnormal exertional fatigue, tremor, and if standing for long, tachycardia, increased tremor, followed in 30 - 60 min. by GI distress. I am MUCH better than I was, but my functioning continues to be impaired.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Magnetic resonance imaging normal, Nerve conduction studies abnormal, Neuropathy peripheral, Orthostatic hypotension
Clinical narrative: Approximately 2 weeks after my 2nd shot in the Pfizer 2-shot initial vaccine series, I developed intense fatigue, orthostatic hypotension, GI distress (low abdominal pain and diarrhea), tremor. If I stop for more than a minute, I developed tachycardia, profuse sweating, weakness /feeling like I was going to faint.  This persisted  in a severe state for 6 months, at which point I slowly became better. During this time, I was non-functional. Oddly, I also developed tiny stinging skin bumps on my torso and arms. At this time, I continue to have abnormal exertional fatigue, tremor, and if standing for long, tachycardia, increased tremor, followed in 30 - 60 min. by GI distress. I am MUCH better than I was, but my functioning continues to be impaired.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Tachycardia, Thyroid function test normal, Tremor
Clinical narrative: Approximately 2 weeks after my 2nd shot in the Pfizer 2-shot initial vaccine series, I developed intense fatigue, orthostatic hypotension, GI distress (low abdominal pain and diarrhea), tremor. If I stop for more than a minute, I developed tachycardia, profuse sweating, weakness /feeling like I was going to faint.  This persisted  in a severe state for 6 months, at which point I slowly became better. During this time, I was non-functional. Oddly, I also developed tiny stinging skin bumps on my torso and arms. At this time, I continue to have abnormal exertional fatigue, tremor, and if standing for long, tachycardia, increased tremor, followed in 30 - 60 min. by GI distress. I am MUCH better than I was, but my functioning continues to be impaired.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Heart rate increased, Hypersensitivity
Clinical narrative: An allergic reaction after I left the Pharmacy. Swelling of the throat, difficult breathing, fast heartbeat, dizziness, headaches, fever and hives and welts severely bad. I' am currently taking XYZAL AND A PEPCID PILL TO CONTROL IT EVERYDAY AND I Have A Epi Pen to carry with me everyday for the rest of my life.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Pyrexia, Urticaria
Clinical narrative: An allergic reaction after I left the Pharmacy. Swelling of the throat, difficult breathing, fast heartbeat, dizziness, headaches, fever and hives and welts severely bad. I' am currently taking XYZAL AND A PEPCID PILL TO CONTROL IT EVERYDAY AND I Have A Epi Pen to carry with me everyday for the rest of my life.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient to receive (Grey Top) Adult 30mcg/0.3ml Booster Dose and received the (Orange Top) diluted 0.2ml. This was discovered upon entering the data into the data base. No adverse reaction was noted. State was contacted and recommended repeating correct dose. Mother notified by the Quality Program MD.
Age: 50.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain
Clinical narrative: Patient called 8/7/22 reporting residual pain at injection site. She describes the site as tender and sore and has never had any pain after injection that has lasted this long (going on 7 days).
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Rash maculo-papular
Clinical narrative: Fever started day 1, still with fever on day 3 up to 103F. Rash started day 2 on stomach (8/5/22) and day 3 was full body, covering face, abdomen, arms, legs, back. Rash was maculopapular, non-itchy.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles outbreak, currently on a anti viral, still in first week or onse.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was  given beyond the use  date by handful of days, no adverse issues at  all. patient fine
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Renal impairment
Clinical narrative: Kidneys diminished to 70% function
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered beyond-use-date. No adverse affects reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pyrexia, Rash
Clinical narrative: Rash all over the body, fever, muscle cramps
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine  administered to  patient  a handful of  days beyond the use date of  the product. No  adverse reactions reported
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient hospitalized.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered beyond-use-date. No adverse effects reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered beyond-use-date. No adverse effects reported.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered a handful of days beyond  use date  of the product. No  adverse  effects reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient hospitalized.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered beyond use  date of the  product by a handful of days.  No  adverse effects reported
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site inflammation, Myositis, Pain
Clinical narrative: Left deltoid inflamed for a year.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash, Rash erythematous, Rash macular, Skin warm
Clinical narrative: Approximately 30 minutes after receiving the COVID booster shot patient began to display a red rash across both cheeks. The rash continued to spread across the cheeks, covering both cheeks from under the eyes to jawline. Rash also spread to splotches across the forehead. One splotch on each side of the neck. Splotches and rash were warm to touch. Child appeared tired, but remained fully responsive and conscious. Denied any evidence of respiratory concerns. Did not show any evidence of mouth swelling. Several places on the cheeks and above the eyebrow appeared slightly puffy, but unable to tell if this was actually puffiness/swelling or normal skin. Symptoms remained for several hours and then began to slowly dissipate. After the first hour they did not increase in intensity or severity. The administering facility was contacted and a message left for a return call. A RN returned the call and recommended monitoring and cool compress, and to seek emergency medical attention if symptoms worsen or trouble breathing or facial swelling. Also recommended to follow up with MD if symptoms do not dissipate. In hindsight, the previous 2 covid vaccine administrations also resulted in splotchy and red cheeks, however mild on the first dose, and moderate on the second and were attributed at the time to chapped skin from the cold wind and/or flushed due to warmth from jacket and scarf.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Approximately 30 minutes after receiving the COVID booster shot patient began to display a red rash across both cheeks. The rash continued to spread across the cheeks, covering both cheeks from under the eyes to jawline. Rash also spread to splotches across the forehead. One splotch on each side of the neck. Splotches and rash were warm to touch. Child appeared tired, but remained fully responsive and conscious. Denied any evidence of respiratory concerns. Did not show any evidence of mouth swelling. Several places on the cheeks and above the eyebrow appeared slightly puffy, but unable to tell if this was actually puffiness/swelling or normal skin. Symptoms remained for several hours and then began to slowly dissipate. After the first hour they did not increase in intensity or severity. The administering facility was contacted and a message left for a return call. A RN returned the call and recommended monitoring and cool compress, and to seek emergency medical attention if symptoms worsen or trouble breathing or facial swelling. Also recommended to follow up with MD if symptoms do not dissipate. In hindsight, the previous 2 covid vaccine administrations also resulted in splotchy and red cheeks, however mild on the first dose, and moderate on the second and were attributed at the time to chapped skin from the cold wind and/or flushed due to warmth from jacket and scarf.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient hospitalized.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was  administered beyond use date of the product by a handful of days. No  adverse effects were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test
Clinical narrative: Had COVID symptoms on 7/29/2022.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Anxiety, Asthenia, Biopsy colon abnormal, Blood test
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring, Change of bowel habit, Chest discomfort, Chest pain, Chiropractic
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Colonoscopy abnormal, Computerised tomogram normal, Cough, Decreased appetite, Dehydration
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Drug hypersensitivity, Dyspnoea, Electrocardiogram normal, Fatigue
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fear, Feeling abnormal, Feeling cold, Fibrin D dimer increased, Full blood count abnormal
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate decreased, Heart rate increased, Hypoaesthesia, Impaired driving ability
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Lymphadenopathy, Migraine, Muscle spasms, Nasal congestion
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Night sweats, Oropharyngeal pain, Platelet count decreased, Pollakiuria
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Polyp, Precancerous lesion of digestive tract, Pregnancy test negative, Pyrexia, Restlessness
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Skull X-ray abnormal, Sleep disorder, Stool analysis, Tachycardia
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, White blood cell count increased
Clinical narrative: On the 7th and for several days after I experienced shortness of breath, increased heart rate, weakness, numbness, and chest pain that continued to worsen, resulting in several ER visits between July and September trying to determine the cause.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Hyperhidrosis, Sleep disorder
Clinical narrative: Shiver, sweat , fatigue  Through the night while sleeping  Symptoms disappeared after waking up  No treatment needed
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: On 8/7/22 around 10:30 am, the father requested for a second dose of Pfizer.  Pfizer 0.2ml was given on the left arm. RN then noticed when filling out the vaccination card that the patient was given Moderna as the first dose. The site lead was immediately notified. It was explained to the father that Moderna was administered as the first dose, not Pfizer. The father was asked to wait 30 minutes for the patient to be observed. The patient did not show any reaction while waiting.  The parent?s information was taken for following up by the site lead. The parent was encouraged to continue monitoring the patient for any reaction and to report to the child?s doctor. The father was contacted by the site lead around 8;45pm. The father responded that patient seems great and had no issues that he could see.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Chest X-ray abnormal, Chest pain, Computerised tomogram thorax normal, Confusional state
Clinical narrative: "parsonage turner syndrome" and, "Unknown paresthesia," "Active Problems:  Cervical pain (neck) Paresthesias", Uncontrollable Shaking, convulsions, confusion, extreme pain that felt like fire in neck legs arms chest feet hands fingers ribs and extreme weakness in both arms both legs, feet, and toes, neuropathy, stiffness, pain in lungs.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Electrocardiogram, Full blood count, Laboratory test, Magnetic resonance imaging spinal abnormal
Clinical narrative: "parsonage turner syndrome" and, "Unknown paresthesia," "Active Problems:  Cervical pain (neck) Paresthesias", Uncontrollable Shaking, convulsions, confusion, extreme pain that felt like fire in neck legs arms chest feet hands fingers ribs and extreme weakness in both arms both legs, feet, and toes, neuropathy, stiffness, pain in lungs.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Musculoskeletal chest pain, Musculoskeletal stiffness, Neck pain, Neuralgic amyotrophy
Clinical narrative: "parsonage turner syndrome" and, "Unknown paresthesia," "Active Problems:  Cervical pain (neck) Paresthesias", Uncontrollable Shaking, convulsions, confusion, extreme pain that felt like fire in neck legs arms chest feet hands fingers ribs and extreme weakness in both arms both legs, feet, and toes, neuropathy, stiffness, pain in lungs.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, Pain, Pain in extremity, Paraesthesia, Pulmonary calcification
Clinical narrative: "parsonage turner syndrome" and, "Unknown paresthesia," "Active Problems:  Cervical pain (neck) Paresthesias", Uncontrollable Shaking, convulsions, confusion, extreme pain that felt like fire in neck legs arms chest feet hands fingers ribs and extreme weakness in both arms both legs, feet, and toes, neuropathy, stiffness, pain in lungs.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary granuloma, Pulmonary pain, Seizure, Spinal osteoarthritis, Tremor
Clinical narrative: "parsonage turner syndrome" and, "Unknown paresthesia," "Active Problems:  Cervical pain (neck) Paresthesias", Uncontrollable Shaking, convulsions, confusion, extreme pain that felt like fire in neck legs arms chest feet hands fingers ribs and extreme weakness in both arms both legs, feet, and toes, neuropathy, stiffness, pain in lungs.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardioversion, Dyspnoea, Echocardiogram abnormal, Electrocardiogram abnormal
Clinical narrative: New Onset Atrial Fibrillation (A-fib); no prior history of A-Fib; started two weeks after my second booster/4th shot -- all four shots/doses we Pfizer Covid-19 vaccine,  I went to doctor due to shortness of breath that lingered for several.  I am very athletic and have strong cardiovascular fitness, so this was unusual.  I was diagnosed on July 8, 2022 with A-fib (by EKG), and then echocardiogram the same day (July 8, 2022)  After receiving mechanical cardioversion, the A-fib has resolved.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: New Onset Atrial Fibrillation (A-fib); no prior history of A-Fib; started two weeks after my second booster/4th shot -- all four shots/doses we Pfizer Covid-19 vaccine,  I went to doctor due to shortness of breath that lingered for several.  I am very athletic and have strong cardiovascular fitness, so this was unusual.  I was diagnosed on July 8, 2022 with A-fib (by EKG), and then echocardiogram the same day (July 8, 2022)  After receiving mechanical cardioversion, the A-fib has resolved.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Client presented to the vaccination site on 08/05/2022 for his Moderna COVID vaccine. Today, the client consented to receive Moderna COVID booster dose #1 (0.25 ml) (Lot #: 006M21A exp: 08/19/22) by LVN. After reviewing the vaccination forms, Staff worker noted that client never receive any primary series which means he is under dose today since the client received administration of the Moderna COVID booster dose #1 instead of a first dose Moderna COVID vaccine (full dose 0.5 ml). Staff worker notified PHN supervisor. PHN supervisor submitted a medical consult via text message to the doctor, requesting for guidance on how to proceed. PHN supervisor received recommendation from the doctor with recommendation to call client to come back today (8/5/22) or tomorrow for the Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine of 0.5 ml. PHN supervisor called client to inform him of the doctor?s recommendation for him to come back for his Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine (full dose of 0.5 cc). PHN supervisor left a message for client to call back since client did not answer his phone. PHN supervisor sent a follow-up text message to the doctor informing him that client did not answer his phone and left him a message for him to call her back. PHN supervisor received a text message from the doctor that the recommendation should be for client return today or tomorrow, and if the client did not answer his phone, then nothing can be done today. PHN supervisor unable to educate client on the side effects of Moderna COVID vaccine since client left the vaccination site before the under dose of Moderna COVID vaccine given was noted and unable to obtain any information if client has any chronic conditions, current medications, or known allergies. PHN supervisor educated LVN on confirming with each client the right client, right vaccine, right dose/time frame, and any history of adverse reactions or known allergies in the future. PHN supervisor notified the PHN lead for the medical Team on 8/7/22, Sunday to call client again to inform client to return 8/7/22, Sunday to receive the Moderna COVID booster dose #2.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, Cardiac failure, Fatigue, Feeling abnormal, Headache
Clinical narrative: A week after vaccination felt miserable.  Severe headache; exhaustion By May excessive leg swelling
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling
Clinical narrative: A week after vaccination felt miserable.  Severe headache; exhaustion By May excessive leg swelling
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Client presented to the vaccination site on 08/05/2022 for her Moderna COVID vaccine. Today, the client consented to receive Moderna COVID booster dose #1 (0.25 ml) (Lot #: 006M21A exp: 08/19/22). After reviewing the vaccination forms, worker noted that client never receive any primary series which means she is under dose today since the client received administration of the Moderna COVID booster #1 instead of a first dose Moderna COVID vaccine (full dose 0.5 ml). worker notified supervisor. supervisor submitted a medical consult via text message to the doctor, requesting for guidance on how to proceed.  supervisor received recommendation from the doctor with recommendation to call client to come back today (8/5/22) or tomorrow for the Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine of 0.5 ml. supervisor called client to inform her of the doctor's recommendation for her to come back for her Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine (full dose of 0.5 cc). Client said to supervisor that she cannot come back until after four weeks. supervisor sent a follow-up text message to the doctor informing him that client cannot come back until after four weeks. supervisor received a text message from the doctor that the recommendation should be for client return today or tomorrow, and if the client decline or cannot come back then nothing can be done today. supervisor unable to educate client on the side effects of Moderna COVID vaccine since client left the vaccination site before the under dose of Moderna COVID vaccine given was noted and unable to obtain any information if client has any chronic conditions, current medications, or known allergies.  supervisor educated on confirming with each client the right client, right vaccine, right dose/time frame, and any history of adverse reactions or known allergies in the future.
Age: 50.0
Sex: M
Vaccine: COVID19, VARZOS
Symptoms: Bell's palsy
Clinical narrative: Bells Palsy
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Pain in extremity, Pulmonary embolism, Restless legs syndrome
Clinical narrative: Narrative: Patient admitted 6/19 to Medical Center with complaints of shortness of breath, chest pain and leg pain. Patient was found to have saddleback pulmonary embolism. 92% oxygen saturation on room air. Patient was immediately brought back for an embolectomy. He was found to have a massive PE bilaterally with the right side almost completely blocked. Procedure was successful. Patient reports to this PharmD that he had previously been seen for leg pain prior to the PE and was diagnosed with RLS. No documents to in our system for that encounter.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Thromboembolectomy
Clinical narrative: Narrative: Patient admitted 6/19 to Medical Center with complaints of shortness of breath, chest pain and leg pain. Patient was found to have saddleback pulmonary embolism. 92% oxygen saturation on room air. Patient was immediately brought back for an embolectomy. He was found to have a massive PE bilaterally with the right side almost completely blocked. Procedure was successful. Patient reports to this PharmD that he had previously been seen for leg pain prior to the PE and was diagnosed with RLS. No documents to in our system for that encounter.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: covid vaccine breakthrough  dose 1 Moderna 2/4/21 038K20A dose 2 Moderna 3/5/21 030A21A dose 3 Moderna 10/26/21 014F21A
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough  dose 1 Moderna 2/4/21 038K20A dose 2 Moderna 3/5/21 030A21A dose 3 Moderna 10/26/21 014F21A
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, with one booster.  COVID breakthrough infeciton
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Psoriasis
Clinical narrative: Psoriasis; This spontaneous case was reported by a physician and describes the occurrence of PSORIASIS (Psoriasis) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    Co-suspect products included non-company products COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for an unknown indication and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form., third dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form and fourth dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced PSORIASIS (Psoriasis). At the time of the report, PSORIASIS (Psoriasis) outcome was unknown.      The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vaccine that expired on 24-April-2022, vial was initially stored in the refrigerator on 23-Jun-2022, unused portion was put in refrigerator; No adverse event; Dose administered after manufacturer date of expiry to 11th patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to 11th patient), PRODUCT STORAGE ERROR (Vaccine that expired on 24-April-2022, vial was initially stored in the refrigerator on 23-Jun-2022, unused portion was put in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jun-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to 11th patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine that expired on 24-April-2022, vial was initially stored in the refrigerator on 23-Jun-2022, unused portion was put in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to 11th patient), PRODUCT STORAGE ERROR (Vaccine that expired on 24-April-2022, vial was initially stored in the refrigerator on 23-Jun-2022, unused portion was put in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to 11th patient) and PRODUCT STORAGE ERROR (Vaccine that expired on 24-April-2022, vial was initially stored in the refrigerator on 23-Jun-2022, unused portion was put in refrigerator).    Concomitant medication details were not reported by the reporter. Vial was initially stored in the refrigerator on 05-MAY-2022, 06-MAY-2022, 19-MAY-2022, 02-JUN-2022, 09-JUN-2022 and 23-JUN-2022. Vial did not undergo any temperature execursion. It was reported that vaccines were removed from the freezer on date of appointments to be used, and any unused portion was put in refrigerator. Treatment details were not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-619547 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-619547:Same reporter
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Nausea
Clinical narrative: Muscle aches; Some joint pain; Headache; Nausea; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Muscle aches), ARTHRALGIA (Some joint pain), HEADACHE (Headache) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 098F21A, 026B21A and 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis (10 years ago, arthritis in knees and hands.), Fibromyalgia (99 percent gone due to being on a gluten free diet.) since 1995, Rheumatic fever (Rheumatic fever as a child), Gluten intolerance (Gluten intolerant), Allergy to antibiotic (Cipro), Sulfonamide allergy (Sulfa), Allergy to antibiotic (Erithromycin), Drug allergy (Steroid), Drug allergy (Motrin), Drug allergy (Advil), Drug allergy (Muscle relaxers) and Drug allergy (Soma).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In 2021, the patient experienced MYALGIA (Muscle aches), ARTHRALGIA (Some joint pain), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, MYALGIA (Muscle aches), ARTHRALGIA (Some joint pain), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.            No concomitant medication details was reported.  The patient had reported after the first three doses, patient experienced some joint pain, muscle aches, headache, and nausea. Patient reported that it was not anything bad and patient could push through with those symptoms for a couple of days.  No treatment medication details was reported.   This case was linked to MOD-2022-619530, MOD-2021-034109, MOD-2021-072834 (Patient Link).
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial used was initially stored in the refrigerator on 30-Jun-2022 and administered on 04-Aug-2022; No adverse event; vaccine was administered after 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was administered after 30 day use by date), PRODUCT STORAGE ERROR (The vial used was initially stored in the refrigerator on 30-Jun-2022 and administered on 04-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     It was unknown if patient had any allergies. It was unknown if patient had event diagnosed with COVID-19. Acute and chronic illnesses at the time of vaccination was unknown.  Previously administered products included for Product used for unknown indication: (Other vaccine given within 1 month prior to Moderna COVID-19 vaccine), DTaP (Other vaccine given within 1 month prior to Moderna COVID-19 vaccine), pneumococcal vaccine (Other vaccine given within 1 month prior to Moderna COVID-19 vaccine) and Hep B (Other vaccine given within 1 month prior to Moderna COVID-19 vaccine). Past adverse reactions to the above products included No adverse event with DTaP, Hep B, and pneumococcal vaccine.    On 04-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was administered after 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial used was initially stored in the refrigerator on 30-Jun-2022 and administered on 04-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine was administered after 30 day use by date), PRODUCT STORAGE ERROR (The vial used was initially stored in the refrigerator on 30-Jun-2022 and administered on 04-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (vaccine was administered after 30 day use by date) and PRODUCT STORAGE ERROR (The vial used was initially stored in the refrigerator on 30-Jun-2022 and administered on 04-Aug-2022).    It was unknown if patient was under any concomitant or regular medication.   Number of doses/vials: 1 dose/1 vial.  The injection was administered in the thigh.  The vial did not undergo any temperature excursions.  It was reported that HCP did not know if patient experienced any symptoms after the vaccine was administered.  It was reported that HCP did not know if any treatment was given.